2Pu YS, Liu CM, Kao JH,et al. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis. Eur Urol, 1999,36: 293-297.
3Kojima M, Kamoi K, Ukimura O, et al. Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer: a preliminary study. Int J Urol,2002,9:42 -46.
4Fritz HS. Hormonal therapy of prostate cancer. In: Walsh PC, Retik AB,Vaughan ED, et al. eds. Campbell' s Urology. Vol 4.8th ed.Philadelphia: Saunders, 2002.3182 -3218.
5Wada T, Ueda MM, Abe K, et al. Risk factor of liver disorders caused by flutamide-statistical analysis using multivariate logistic regression analysis. Hinyokika Kiyo, 1999,45:521-526.
